Drug record
What four public record sets show for furosemide. Saved Nov 10, 2026.
| Shortage | On the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.025 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $146.6 million | Details |
| FDA recall records | 14 | Details |
Whether the FDA lists this drug as in short supply.
Reason given: Other
Reason given: Requirements related to complying with good manufacturing practices
Reason given: Requirements related to complying with good manufacturing practices
Reason given: Discontinuation of the manufacture of the drug
Reason given: Discontinuation of the manufacture of the drug
Reason given: Other
Reason given: Other
Reason given: Requirements related to complying with good manufacturing practices
Reason given: Demand increase for the drug
Reason given: Other
Reason given: Discontinuation of the manufacture of the drug
3 products being discontinued. A maker has told the FDA it will stop making these. That is one maker leaving, not a shortage of the drug:
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Furosemide 20 Mg Tablet: pharmacies pay about $0.025 each, or $0.748 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| FUROSEMIDE 1,000 MG/100 ML VL | Generic | $0.265 per mL | — | Oct 21, 2026 |
| FUROSEMIDE 10 MG/ML SOLUTION | Generic | $0.093 per mL | — | Oct 21, 2026 |
| FUROSEMIDE 100 MG/10 ML VIAL | Generic | $0.265 per mL | — | Oct 21, 2026 |
| FUROSEMIDE 20 MG TABLET | Generic | $0.025 per each | $0.748 | Oct 21, 2026 |
| FUROSEMIDE 20 MG/2 ML VIAL | Generic | $0.529 per mL | — | Oct 21, 2026 |
| FUROSEMIDE 40 MG TABLET | Generic | $0.029 per each | $0.863 | Oct 21, 2026 |
| FUROSEMIDE 40 MG/4 ML ORAL SOLUTION CUP | Generic | $0.093 per mL | — | Oct 21, 2026 |
| FUROSEMIDE 40 MG/4 ML VIAL | Generic | $0.265 per mL | — | Oct 21, 2026 |
| FUROSEMIDE 500 MG/50 ML VIAL | Generic | $0.529 per mL | — | Oct 21, 2026 |
| FUROSEMIDE 80 MG TABLET | Generic | $0.050 per each | $1.49 | Oct 21, 2026 |
| LASIX 20 MG TABLET | Brand | $0.749 per each | $22.46 | Oct 21, 2026 |
| LASIX 40 MG TABLET | Brand | $1.05 per each | $31.38 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $146.6 million for the 3 products below. That is down 1% from $148.2 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Furosemide* Furosemide | $118.9 million | 5,790,198 | $5.05 | $20.54 | $147.1 million |
| Furoscix Furosemide | $27.2 million | 3,059 | $6,229.65 | $8,885.24 | — |
| Lasix Furosemide | $507,435 | 2,262 | $76.11 | $224.33 | $1.0 million |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 14 recall records that name furosemide in the product description (1 Class I · 11 Class II · 2 Class III). 3 are still marked ongoing.
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
Reason: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
Reason: Presence of Foreign Substance
Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL Injection, 100 mL Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205, 877.550.5059, barcode 70004063032.
Reason: Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide.
Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-4297-31.
Reason: Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.
Furosemide 20 mg/mL svn Sol, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938
Reason: Lack of Assurance of Sterility
FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216, NDC 0054-4297-31, UPC 3 0054-4297-31 8.
Reason: CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.
FUROSEMIDE Tablets USP, 40 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216, NDC 0054-4299-31, UPC 3 0054-4299-31 2.
Reason: CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.
Furosemide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Reason: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
FUROSEMIDE 10 MG/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI
Reason: Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Furosemide 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Furosemide Injection, all strengths and all presentations including a) Furosemide PF-10 mg-10 mL, b) Furosemide PF-10 mg-2 mL SDV, and Furosemide 10 mg/mL 4 mL SDV, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.
Reason: Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Furosemide Injection, USP, 40 mg/4mL (10 mg/mL), 4 ml Single-Dose Vial, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-6102-04
Reason: Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for furosemide. This page is public-record information, not medical advice.